ENDOLOGIX RECEIVES FDA APPROVAL TO MARKET VISIFLEX DELIVERY SYSTEM

Endologix Inc. said it received U.S. Food and Drug Administration approval to begin marketing its next-generation Visiflex Delivery System for use with the Powerlink System to treat abdominal aortic aneurysm.
Trading Markets Live